Apollo Hospitals Enterprise Limited vs Max Healthcare Institute Limited
An objective side-by-side of APOLLOHOSP and MAXHEALTH, both in Healthcare: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-09-21 close
Latest results: APOLLOHOSP Mar 2026 · MAXHEALTH Jun 2026
At a glance
- Apollo Hospitals Enterprise Limited is the larger company by market value, about 1.2 times the size of Max Healthcare Institute Limited.
- On trailing earnings, Apollo Hospitals Enterprise Limited trades at the lower P/E (64.0 against 71.2).
- Apollo Hospitals Enterprise Limited earns the higher return on equity (21.1% against 13.6%).
- Over three years Apollo Hospitals Enterprise Limited has grown profits faster (34% a year against 10%).
- Over the past year the share prices returned +14.0% (APOLLOHOSP) and -9.3% (MAXHEALTH).
| Metric | Apollo Hospitals APOLLOHOSP |
Max Healthcare MAXHEALTH |
|---|---|---|
| Size and price | ||
| Market cap | ₹128,141 Cr | ₹103,813 Cr |
| Share price | ₹8,912 | ₹1,067 |
| Valuation | ||
| P/E | 64.00 | 71.24 |
| P/B | 13.52 | 9.66 |
| EV/EBITDA | 36.25 | 46.29 |
| PEG | 1.88 | 7.12 |
| Dividend yield | 0.2% | 0.1% |
| Profitability | ||
| ROE | 21.1% | 13.6% |
| ROCE | 18.0% | 15.0% |
| Operating margin | 14.9% | 26.6% |
| Sales (TTM) | ₹25,229 Cr | ₹8,712 Cr |
| Net profit (TTM) | ₹2,002 Cr | ₹1,457 Cr |
| Growth | ||
| Latest quarter sales YoY | +18.1% | +16.7% |
| Latest quarter profit YoY | +32.9% | +4.9% |
| Sales CAGR 3Y | +15.0% | +22.0% |
| Profit CAGR 3Y | +34.0% | +10.0% |
| Sales CAGR 5Y | +19.0% | +27.0% |
| Profit CAGR 5Y | +78.0% | +60.0% |
| Financial strength | ||
| Debt/Equity | 0.90 | 0.32 |
| Interest cover | 6.44 | 7.63 |
| Ownership | ||
| Promoter holding | 28.0% | 23.7% |
| Promoter change (4 qtrs) | -1.32 pp | -0.03 pp |
| Price performance | ||
| Return 1M | +2.03% | +6.88% |
| Return 3M | +5.23% | -2.60% |
| Return 1Y | +14.02% | -9.26% |
| Return YTD | +26.55% | +2.06% |
| Technical condition | ||
| Technical score | 80 | 76 |
| RS rating (1-99) | 70.00 | 51.00 |
| % vs 200-DMA | +11.95% | +2.78% |
| RSI (14) | 55.05 | 61.95 |
| % from 52-week high | -1.52% | -12.71% |
